| The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44 C Liu, K Kelnar, B Liu, X Chen, T Calhoun-Davis, H Li, L Patrawala, H Yan, ... Nature medicine 17 (2), 211-215, 2011 | 1623 | 2011 |
| Oncogenic PI3K deregulates transcription and translation AG Bader, S Kang, L Zhao, PK Vogt Nature Reviews Cancer 5 (12), 921-929, 2005 | 1074 | 2005 |
| Phosphatidylinositol 3-kinase mutations identified in human cancer are oncogenic S Kang, AG Bader, PK Vogt Proceedings of the National Academy of Sciences 102 (3), 802-807, 2005 | 1022 | 2005 |
| Development of a lung cancer therapeutic based on the tumor suppressor microRNA-34 JF Wiggins, L Ruffino, K Kelnar, M Omotola, L Patrawala, D Brown, ... Cancer research 70 (14), 5923-5930, 2010 | 809 | 2010 |
| Systemic delivery of tumor suppressor microRNA mimics using a neutral lipid emulsion inhibits lung tumors in mice P Trang, JF Wiggins, CL Daige, C Cho, M Omotola, D Brown, ... Molecular Therapy 19 (6), 1116-1122, 2011 | 802 | 2011 |
| Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors MS Beg, AJ Brenner, J Sachdev, M Borad, YK Kang, J Stoudemire, ... Investigational new drugs 35, 180-188, 2017 | 795 | 2017 |
| The let-7 microRNA reduces tumor growth in mouse models of lung cancer A Esquela-Kerscher, P Trang, JF Wiggins, L Patrawala, A Cheng, L Ford, ... Cell cycle 7 (6), 759-764, 2008 | 784 | 2008 |
| miR-34–a microRNA replacement therapy is headed to the clinic AG Bader Frontiers in genetics 3, 28826, 2012 | 767 | 2012 |
| The promise of microRNA replacement therapy AG Bader, D Brown, M Winkler Cancer research 70 (18), 7027-7030, 2010 | 743 | 2010 |
| Regression of murine lung tumors by the let-7 microRNA P Trang, PP Medina, JF Wiggins, L Ruffino, K Kelnar, M Omotola, ... Oncogene 29 (11), 1580-1587, 2010 | 622 | 2010 |
| PDL1 Regulation by p53 via miR-34 MA Cortez, C Ivan, D Valdecanas, X Wang, HJ Peltier, Y Ye, L Araujo, ... Journal of the National Cancer Institute 108 (1), djv303, 2016 | 598 | 2016 |
| Phase 1 study of MRX34, a liposomal miR-34a mimic, in patients with advanced solid tumours DS Hong, YK Kang, M Borad, J Sachdev, S Ejadi, HY Lim, AJ Brenner, ... British journal of cancer 122 (11), 1630-1637, 2020 | 557 | 2020 |
| Cancer-specific mutations in PIK3CA are oncogenic in vivo AG Bader, S Kang, PK Vogt Proceedings of the National Academy of Sciences 103 (5), 1475-1479, 2006 | 529 | 2006 |
| Systemic delivery of synthetic microRNA-16 inhibits the growth of metastatic prostate tumors via downregulation of multiple cell-cycle genes F Takeshita, L Patrawala, M Osaki, R Takahashi, Y Yamamoto, N Kosaka, ... Molecular Therapy 18 (1), 181-187, 2010 | 510 | 2010 |
| Developing therapeutic microRNAs for cancer AG Bader, D Brown, J Stoudemire, P Lammers Gene therapy 18 (12), 1121-1126, 2011 | 410 | 2011 |
| A combinatorial microRNA therapeutics approach to suppressing non-small cell lung cancer AL Kasinski, K Kelnar, C Stahlhut, E Orellana, J Zhao, E Shimer, S Dysart, ... Oncogene 34 (27), 3547-3555, 2015 | 236 | 2015 |
| Therapeutic delivery of miR-200c enhances radiosensitivity in lung cancer MA Cortez, D Valdecanas, X Zhang, Y Zhan, V Bhardwaj, GA Calin, ... Molecular Therapy 22 (8), 1494-1503, 2014 | 218 | 2014 |
| Phosphatidylinositol 3-kinase: the oncoprotein PK Vogt, JR Hart, M Gymnopoulos, H Jiang, S Kang, AG Bader, L Zhao, ... Phosphoinositide 3-kinase in Health and Disease: Volume 2, 79-104, 2011 | 170 | 2011 |
| Systemic microRNA-34a delivery induces apoptosis and abrogates growth of diffuse large B-cell lymphoma in vivo VJ Craig, A Tzankov, M Flori, CA Schmid, AG Bader, A Müller Leukemia 26 (11), 2421-2424, 2012 | 132 | 2012 |
| Inhibition of protein synthesis by Y box-binding protein 1 blocks oncogenic cell transformation AG Bader, PK Vogt Molecular and cellular biology, 2005 | 131 | 2005 |
